Published in Cancer on June 15, 2000
Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol (2009) 2.11
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol (2003) 1.49
Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head Neck Oncol (2011) 1.48
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol (2010) 1.48
Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol (2011) 1.08
Imatinib in the treatment of dermatofibrosarcoma protuberans. Biologics (2007) 1.07
Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans. Sarcoma (2011) 1.01
Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Ann Surg Oncol (2010) 0.97
Considerations for tissue expansion in the management of massive dermatofibrosarcoma protuberans of the head and neck. Eplasty (2013) 0.95
Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report. Clin Sarcoma Res (2013) 0.90
Genetic aberrations in imatinib-resistant dermatofibrosarcoma protuberans revealed by whole genome sequencing. PLoS One (2013) 0.89
Dermatofibrosarcoma protuberans of the scalp with fibrosarcomatous degeneration and pulmonary metastasis. J Clin Imaging Sci (2011) 0.89
Wide Local Excision for Dermatofibrosarcoma Protuberans: A Single-Center Series of 90 Patients. Biomed Res Int (2015) 0.87
Obesity does not affect survival outcomes in extremity soft tissue sarcoma. Clin Orthop Relat Res (2014) 0.87
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans. Mol Cancer Ther (2015) 0.85
Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature. Clin Sarcoma Res (2014) 0.85
Unusual presentation of dermatofibrosarcoma protuberans in a male patient's breast: a case report and review of the literature. World J Surg Oncol (2015) 0.85
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. Clin Sarcoma Res (2012) 0.84
Influence of resident education in correctly diagnosing extremity soft tissue sarcoma. Sarcoma (2013) 0.84
Dermatofibrosarcoma protuberans: from translocation to targeted therapy. Cancer Biol Med (2015) 0.82
Magnetic resonance imaging and mammographic appearance of dermatofibrosarcoma protuberans in a male breast: a case report and literature review. J Med Case Rep (2009) 0.82
Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not? J Clin Aesthet Dermatol (2011) 0.81
Soft tissue tumors of the anorectum: rare, complex and misunderstood. J Gastrointest Oncol (2013) 0.81
Risk factors for distant metastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol (2016) 0.78
Abdominoplasty and thoraco-epigastric flaps for large anterior trunk defects after dermatofibrosarcoma protuberans wide resection: Two illustrative cases. Int J Surg Case Rep (2012) 0.78
Dermatofibrosarcoma protuberans with pit-like lesions: A case report and literature review. Oncol Lett (2015) 0.77
Dermatofibrosarcoma protuberans: a study of clinical, pathologic, genetic, and therapeutic features in Korean patients. Yonsei Med J (2015) 0.77
Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans--a case report. Oral Maxillofac Surg (2008) 0.76
Advances in sarcoma diagnostics and treatment. Oncotarget (2016) 0.75
Lymph node metastasis after a soft tissue sarcoma of the leg: a case report and a review of the literature. Case Rep Surg (2013) 0.75
Dermatofibrosarcoma: a rare neoplasm of skin. BMJ Case Rep (2012) 0.75
Surgical Treatment of Dermatofibrosarcoma Protuberans Using a Reversed Adipofascial Sural Flap - Case Report. Clujul Med (2014) 0.75
Complete remission of a periorbital dermatofibrosarcoma protuberans with adjuvant imatinib mesylate in a child. JAAD Case Rep (2015) 0.75
A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control. World J Surg Oncol (2017) 0.75
Advances in the systemic treatment of cutaneous sarcomas. Semin Oncol (2012) 0.75
Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib. Int J Clin Exp Med (2015) 0.75
Dermatofibrosarcoma Protuberans. Curr Treat Options Oncol (2017) 0.75
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med (2001) 16.65
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24
Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15
Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90
Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 3.85
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol (1998) 3.10
Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98
Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors). Cancer (1973) 2.97
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77
Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer (1990) 2.74
Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev (2000) 2.72
Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol (1993) 2.71
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65
Community health worker performance in the management of multiple childhood illnesses: Siaya District, Kenya, 1997-2001. Am J Public Health (2001) 2.64
Soft tissue sarcomas. Curr Probl Surg (1996) 2.62
Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer (1989) 2.57
The enigma of desmoid tumors. Ann Surg (1999) 2.57
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol (1996) 2.31
Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol (1999) 2.30
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22
Paragangliomas of the head and neck region: a clinical study of 69 patients. Cancer (1977) 2.18
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med (1999) 2.15
Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol (1997) 2.10
Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09
Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg (1993) 2.07
Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06
Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer (1982) 2.06
Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05
Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma. Int J Radiat Oncol Biol Phys (1988) 2.04
Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03
Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (1999) 2.03
Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest (1998) 2.02
Surgical management of intra-abdominal desmoid tumours. Br J Surg (2000) 2.01
Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg (1996) 1.97
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors. Cancer (1990) 1.97
Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination. Arch Surg (1993) 1.94
Adult urological sarcoma. J Urol (1992) 1.94
Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg (1992) 1.92
Heteroclitic immunization induces tumor immunity. J Exp Med (1998) 1.92
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol (2000) 1.91
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.90
Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg (2000) 1.88
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86